Ian Tannock's guest appearances

Ian Tannock

The JNCI Podcast

Plenary Session

Marty Makary

Adam Cifu

Vinay Prasad

Jenny Gill

Tom DeLoughery

Dan Morgan

John Ioannidis

David Carr

Ameet Sarpatwari

Matthew Smith

Brian Chan

Raj Chetty

Avi Loeb

Heinz-Josef Lenz

Alan Venook

OwlTail

This week's episode is jam-packed with topics! We talk about the RECOVERY trial, the U.S. clinical trial infrastructure, event-free survival (EFS) and cost of care in acute myeloid leukemia, how long it takes to write papers in academic medicine, threats to public health officials, and the application to medicine of Dr. Raj Chetty's work in economics. Finally, we interview this week's special guest, Dr. Ian Tannock, on docetaxel, prostrate cancer, clinical trial appraisal, and his career in medicine.RECOVERY: https://www.recoverytrial.net/EFS in AML: doi.org/10.1182/bloodadvances.2019001150Malignant audiobook: https://www.audible.com/pd/B08864KFHW/?source_code=AUDFPWS0223189MWT-BK-ACX0-195112&amp;ref=acx_bty_BK_ACX0_195112_rh_usBack us on Patreon! www.patreon.com/plenarysession

This week's episode is jam-packed with topics! We talk about the RECOVERY trial, the U.S. clinical trial infrastructure, event-free survival (EFS) and cost of care in acute myeloid leukemia, how long it takes to write papers in academic medicine, threats to public health officials, and the application to medicine of Dr. Raj Chetty's work in economics. Finally, we interview this week's special guest, Dr. Ian Tannock, on docetaxel, prostrate cancer, clinical trial appraisal, and his career in medicine. RECOVERY: <a href="https://www.recoverytrial.net/" rel="nofollow" target="_blank">https://www.recoverytrial.net/</a> EFS in AML: <a href="http://doi.org/10.1182/bloodadvances.2019001150" rel="nofollow" target="_blank">doi.org/10.1182/bloodadvances.2019001150</a> Malignant audiobook: <a href="https://www.audible.com/pd/B08864KFHW/?source_code=AUDFPWS0223189MWT-BK-ACX0-195112&amp;ref=acx_bty_BK_ACX0_195112_rh_us" rel="nofollow" target="_blank">https://www.audible.com/pd/B08864KFHW/?source_code=AUDFPWS0223189MWT-BK-ACX0-195112&amp;ref=acx_bty_BK_ACX0_195112_rh_us</a> Back us on Patreon! <a href="http://www.patreon.com/plenarysession" rel="nofollow" target="_blank">www.patreon.com/plenarysession</a>

2.57 RECOVERY, Clinical Trials in the US, EFS, Writing, Dr. Raj Chetty, & Dr. Ian Tannock

Ian Tannock discusses how the tumor microenvironment contributes to drug resistance.

Ian Tannock interview on drug resistance and the tumor microenvironment